These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 12949688)

  • 1. Use of potentiated preparations to relieve alcohol and opium withdrawal syndromes.
    Aleksandrova NV; Gofman AG; Krylov EN; Epstein OI
    Bull Exp Biol Med; 2003 Jan; 135 Suppl 7():163-6. PubMed ID: 12949688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of ANAR for the therapy of opium withdrawal syndrome.
    Gofman AG; Krylov EN; Kozhinova TA; Nizhnichenko TI; Khanykov VV; Sheveleva OS; Epstein OI; Yashkina IV
    Bull Exp Biol Med; 2003 Jan; 135 Suppl 7():181-2. PubMed ID: 12949692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical evaluation of non-narcotic substitutive effects produced by ANAR during the therapy of patients with heroin abuse.
    Krylov EN
    Bull Exp Biol Med; 2003 Jan; 135 Suppl 7():183-8. PubMed ID: 12949693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proproten-100 in the therapy of patients with the alcohol withdrawal syndrome.
    Gofman AG; Pyatnitskaya IN; Valentik YV; Krylov EN; Epstein OI
    Bull Exp Biol Med; 2003 Jan; 135 Suppl 7():167-70. PubMed ID: 12949689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychotropic activity of the antialcohol preparation Proproten-100.
    Krylov EN
    Bull Exp Biol Med; 2003 Jan; 135 Suppl 7():176-80. PubMed ID: 12949691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphine suppression of ethanol withdrawal in mice.
    Blum K; Wallace JE; Schwerter HA; Eubanks JD
    Experientia; 1976 Jan; 32(1):79-82. PubMed ID: 942927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of psychotropic agents on the manifestation of the morphine abstinence syndrome in mice].
    Patkina NA; Evartau EE
    Farmakol Toksikol; 1980; 43(1):19-23. PubMed ID: 7189719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Double-blind study of the efficacy of tetrabamate and tiapride in the treatment of alcohol deprivation syndrome].
    Santo Domingo Carrasco J; Bravo Ortiz MF; Barroso Cañizares A; Caballero Martín L
    Med Clin (Barc); 1985 Oct; 85(13):533-6. PubMed ID: 3908847
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of several psychotropic agents on changes in the behavior of mice induced by acetaldehyde].
    Andronova LM; Barkov NK; Vikhliaev IuI
    Farmakol Toksikol; 1978; 41(6):660-5. PubMed ID: 31298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study on the detoxification of alcohol extracts from orientvine and its effective component on withdrawal syndromes of morphine].
    Zhang GM; Mo ZX; Wang CY
    Zhong Yao Cai; 2009 Sep; 32(9):1414-8. PubMed ID: 20034221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of allyphenyline efficacy in the treatment of alcohol withdrawal symptoms.
    Ubaldi M; Del Bello F; Domi E; Pigini M; Nasuti C
    Eur J Pharmacol; 2015 Aug; 760():122-8. PubMed ID: 25895641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of drugs on barbiturate withdrawal convulsions in the rat.
    Norton PR
    J Pharm Pharmacol; 1970 Oct; 22(10):763-6. PubMed ID: 4394782
    [No Abstract]   [Full Text] [Related]  

  • 13. Morphine withdrawal in the rat: assessment by quantitation of diarrhea and modification by ethanol.
    Ho AK; Chen RC; Kreek MJ
    Pharmacology; 1979; 18(1):9-17. PubMed ID: 570271
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of psychotropic drugs on sleep disorders in rats during alcohol withdrawal].
    Burov IuV; Viglinskaia IV
    Biull Eksp Biol Med; 1981 Jun; 91(6):689-91. PubMed ID: 7196780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethanol for the treatment of alcohol withdrawal symptoms: a questionable approach.
    Müller CA; Hein J
    Neurologist; 2010 May; 16(3):211. PubMed ID: 20445435
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of acute intoxication and of alcohol withdrawal reaction].
    Chassé M; Bruneau J
    Union Med Can; 1982 Mar; 111(3):229-33. PubMed ID: 7080271
    [No Abstract]   [Full Text] [Related]  

  • 17. The management of alcohol withdrawal.
    Foy A
    Med J Aust; 1986 Jul; 145(1):24-7. PubMed ID: 3523177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of development of tolerance and dependence to opiate in mice by BR-16A (Mentat), a herbal psychotropic preparation.
    Kulkarni SK; Verma A
    Indian J Exp Biol; 1992 Oct; 30(10):885-8. PubMed ID: 1293013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of magnesium sulfate in alcohol withdrawal.
    Embry CK; Lippmann S
    Am Fam Physician; 1987 May; 35(5):167-70. PubMed ID: 3577989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Alcohol withdrawal syndrome. Effects of short-term treatment with dapiprazole].
    Bono G; Verri AP; Merlo P; Mancuso A; Sinforiani E; Mazzella GL
    Minerva Med; 1988 Dec; 79(12):1085-9. PubMed ID: 2905435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.